Mandeep R Mehra is an expert in Cardiology at Brigham and Women's Hospital (United States). As of October 2026, ScienceLeadR ranks Mandeep R Mehra in the top 1% of experts worldwide for Heart Transplantation, Lung Transplantation and Heart Failure. Mandeep R Mehra has authored 870 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 2 of them ongoing. SLR score: 3,564 (community average: 125). How the SLR is computed.

LeadR Profile

Mandeep R Mehra Brigham and Women's Hospital United States
3 564 ScienceLeadR Reputation 3564
Network Map

Cardiology

Subspecialties: Transplantation - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Professor (Dr.) Mehra holds the William Harvey Chair in Advanced Cardiovascular Medicine, Executive Director of the Center for Advanced Heart Disease at Brigham and Women’s Hospital and is a Professor of Medicine at Harvard Medical School. and was the founding Medical Director of the Heart and Vascular Center at Brigham and Women’s Hospital (2013-2019). He served as Editor-in-Chief of The Journal of Heart and Lung Transplantation from 2010 to 2020, and President of the International Society of Heart and Lung Transplantation (ISHLT) in 2008 and Heart Failure Society of America (HFSA) in 2016. He has also been conferred an Honorary Master’s degree from Harvard University, earned a certificate in Executive Leadership from Harvard Business School and a Master of Science in Health Economics and Management from the London School of Economics (as a Braunwald Scholar). In 2024, he was received the Lifetime Achievement Award from the HFSA.


His scholarly work focuses on Advanced Heart Failure, with practice defining contributions to the fields of cardiac transplantation and mechanical circulatory support. Dr. Mehra is regarded as one of the leading global experts in these areas, with his groundbreaking research, innovations, and contributions to practice guidelines helping to shape the future of advanced heart failure care.

Organizations

Career arc: 1994 - 2026

Source: PubMed

Brigham and Women's Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 870

Citations

Citations: 49 993 1st author: 147 Last author: 290 Unique author: 32


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Real World Adoption and Associated Outcomes of Aspirin Avoidance After HeartMate 3 Implantation: The PRAISE HM3 Study.
PMID 42863594 — thromboembolism, hemorrhage, stroke, heart failure, aspirin, vascular diseases, records
J Card Fail20260
Artificial Intelligence-Enabled Detection and Management of Physiological Instability in Heart Failure: Results of the Randomized LINK-HF2 Trial.
PMID 42853165 — intelligence, monitoring, ambulatory, hospitalization, heart failure, heart, artificial intelligence
JACC Heart Fail20260
Rebuilding the Advanced Heart Failure Fellowship Pipeline: By Design, Not Exhortation.
PMID 42788922 — heart failure, heart
JACC Heart Fail20260
An optimally engineered pump, yet an incomplete therapy: biology, residual risk, and the future of LVAD care.
PMID 42770518 — cardiology, therapeutics
Eur Heart J Top journal20261
Impact of personalized risk communication on patient understanding and decision-making in LVAD therapy.
PMID 42731198 — mental recall, communication, decision making, therapeutics, counseling, education, patient education as topic
Patient Educ Couns20260

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 15
Phase 3 2
Phase 4 2
Phase 2 1

By status:

Completed 12
Active not recruiting 3
Terminated 2
Unknown 2
Recruiting 1

By type:

Interventional 18
Observational 2

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 1
multicentric5to9 3
multicentricup10 11

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Early Feasibility Study of the NORM System in Heart Failure Patients (FUTURE HFII)
NCT05763407 — feasibility studies, heart failure, heart, cardiovascular diseases
N/AActive not recruiting2023
Sacubitril Valsartan in Left Ventricular Assist Device Recipients
NCT04103554 — pilot projects, pilots, valsartan, heart failure, pharmaceutical preparations, heart, drug combinations
Phase 4Active not recruiting2021

LeadR Networks

Main global connection map